ORTHOPEDIATRICS CORP
KIDSNasdaq
$19.22
↓ -5.7%Jul 17 close · end-of-day
Price
1Y↓ -14.8%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$455.1M
Enterprise Value
$508.9M
P/E
—
P/S
1.9
P/B
1.3
EV/EBITDA
—
PEG
—
FCF Yield
-2.8%
Dividend Yield
—
Revenue (TTM)
$243.3M
Net Income (TTM)
-$39.7M
Free Cash Flow (TTM)
-$12.6M
Gross Margin
73.1%
Operating Margin
-15.0%
Net Margin
-16.3%
ROE
-11.7%
ROIC
-7.4%
Debt / Equity
0.3
Net Cash
-$53.8M
Return 1Y
-15.2%
Company profile
OrthoPediatrics Corp. designs, develops, markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the. treatment of spinal deformity; and sports medicine and other products.
- CEO
- David R. Bailey
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 200
- Headquarters
- Indiana
- Website
- orthopediatrics.com
Management & directors
- Bailey David RPresident and CEO
- Gerritzen Daniel JGeneral Counsel and Secretary
- Hauser Joseph WPres. Trauma & Def. Correction
- Hite FredCOO and CFO
- Odle Gregory APresident of Scoliosis
Roles derived from SEC Form 4 filings.
Earnings
KIDS Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$59.4M↑ +13.3%
Diluted EPS-$0.45↓ -2.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $71.1M | $98.0M | $122.3M | $148.7M | $204.7M | $236.3M |
| Gross profit | $55.0M | $73.4M | $90.7M | $111.3M | $148.6M | $172.7M |
| Operating income | -$26.8M | -$18.0M | -$25.4M | -$26.8M | -$35.0M | -$39.2M |
| Net income | -$32.9M | -$16.3M | $1.3M | -$21.0M | -$37.8M | -$39.6M |
| Diluted EPS | -$1.82 | -$0.84 | $0.06 | -$0.92 | -$1.64 | -$1.69 |
| Operating cash flow | -$18.5M | -$13.1M | -$21.8M | -$27.0M | -$27.0M | -$4.9M |
| Free cash flow | -$29.0M | -$21.2M | -$31.8M | -$43.9M | -$41.3M | -$16.0M |
| Gross margin | 77.4% | 74.9% | 74.1% | 74.8% | 72.6% | 73.1% |
| Operating margin | -37.6% | -18.4% | -20.8% | -18.0% | -17.1% | -16.6% |
| Net margin | -46.3% | -16.6% | 1.0% | -14.1% | -18.5% | -16.8% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $52.8M | $54.6M | $52.7M | $52.4M | $61.1M | $61.3M | $61.6M | $59.4M |
| Gross profit | $40.8M | $40.1M | $35.6M | $38.3M | $44.0M | $45.3M | $45.1M | $43.4M |
| Operating income | -$5.7M | -$5.6M | -$14.1M | -$11.0M | -$10.7M | -$9.4M | -$8.2M | -$8.3M |
| Net income | -$6.0M | -$7.9M | -$16.1M | -$10.7M | -$7.1M | -$11.8M | -$10.1M | -$10.7M |
| Diluted EPS | -$0.26 | -$0.34 | -$0.70 | -$0.46 | -$0.30 | -$0.50 | -$0.43 | -$0.45 |
| Operating cash flow | -$6.1M | -$10.3M | -$4.0M | -$4.2M | -$10.5M | -$581,000.00 | $10.3M | -$3.3M |
| Free cash flow | -$12.8M | -$11.7M | -$4.2M | -$8.4M | -$13.9M | -$3.4M | $9.7M | -$5.0M |
| Gross margin | 77.3% | 73.4% | 67.5% | 73.0% | 72.1% | 73.9% | 73.2% | 73.1% |
| Operating margin | -10.7% | -10.2% | -26.7% | -21.0% | -17.4% | -15.4% | -13.3% | -14.0% |
| Net margin | -11.4% | -14.5% | -30.5% | -20.3% | -11.6% | -19.2% | -16.4% | -18.0% |
Company news
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-09 | Pelizzon David R | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Hughes Bryan W | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Fischer Kelly Laine | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Riccitelli Samuel D | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Ruf Harold | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Bailey David R· President and CEO | Award | 119,140 | $0.00 | $0.00 | filing |
| 2026-06-09 | McDonald Jimmy Duane | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Infante (Reynolds) Marie C | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Throdahl Mark C | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-06-09 | Dyer George Sinclair Mitchell | Award | 11,436 | $0.00 | $0.00 | filing |
| 2026-05-13 | Gerritzen Daniel J· General Counsel and Secretary | Gift | 2,479 | $0.00 | $0.00 | filing |
| 2026-03-16 | Bailey David R· President and CEO | Sale | 19,535 | $17.25 | $336,978.75 | filing |
| 2026-03-16 | Hite Fred· COO and CFO | Sale | 12,993 | $17.25 | $224,129.25 | filing |
| 2026-03-16 | Gerritzen Daniel J· General Counsel and Secretary | Sale | 8,614 | $17.25 | $148,591.50 | filing |
| 2026-03-16 | Hauser Joseph W· Pres. Trauma & Def. Correction | Sale | 8,596 | $17.25 | $148,281.00 | filing |
| 2026-03-16 | Odle Gregory A· President of Scoliosis | Sale | 8,433 | $17.25 | $145,469.25 | filing |
| 2026-03-15 | Hauser Joseph W· Pres. Trauma & Def. Correction | Award | 65,700 | $0.00 | $0.00 | filing |
| 2026-03-15 | Hite Fred· COO and CFO | Award | 77,405 | $0.00 | $0.00 | filing |
| 2026-03-15 | Odle Gregory A· President of Scoliosis | Award | 47,380 | $0.00 | $0.00 | filing |
| 2026-03-15 | Gerritzen Daniel J· General Counsel and Secretary | Award | 47,380 | $0.00 | $0.00 | filing |
| 2025-12-29 | Bailey David R· President and CEO | Gift | 1,600 | $0.00 | $0.00 | filing |
| 2025-11-10 | Fischer Kelly Laine | Award | 4,345 | $0.00 | $0.00 | filing |
| 2025-08-21 | Hite Fred· COO and CFO | Buy | 5,076 | $19.41 | $98,525.16 | filing |
Latest 23 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.